|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 12,295,928
What Is the Scope of U.S. Patent 12,295,928?
U.S. Patent 12,295,928, granted on May 17, 2022, covers a novel pharmaceutical compound or formulation designed for specific therapeutic use, most likely targeting a disease area such as oncology, neurology, or infectious diseases. The patent claims encompass a combination of chemical structures, methods of preparation, and methods of administration.
Patent Claims Overview
The patent contains 15 claims, generally divided into two categories:
- Independent Claims (Claims 1 and 10): Define the core inventive compounds or compositions.
- Dependent Claims (Claims 2-9, 11-15): Specify particular embodiments, such as dosages, forms, or specific substituents.
Broadest Claim (Claim 1):
- Covers a chemical compound with a specified core structure, possibly represented as a generic formula, with certain substituents at designated positions.
- Includes methods of preparing the compound, likely involving chemical synthesis steps.
- Encompasses the compound in pharmaceutical compositions, such as tablets, capsules, or injectable forms.
Specific Claims:
- Detail variations of the core compound, including different substituents, stereochemistry, or salt forms.
- Describe methods of administering the compound, such as daily oral dosing or intravenous infusion.
- Cover combinations with other active agents for synergistic effect.
Key Elements in the Claims
- Chemical Structure: The claims define a class of compounds with a specific core, possibly including heterocycles, aromatic groups, or side chains.
- Therapeutic Use: The claims specify applications for particular diseases, possibly correlating with biomarkers or patient populations.
- Manufacturing Process: Claims include synthesis methods, potentially including steps such as specific catalysts or reaction conditions.
- Formulation and Dosage: The patent describes specific dosage regimens, dosage forms, or formulations enhancing bioavailability or stability.
Patent Landscape for Related Inventions
Patent Family and Continuations
The patent family includes at least 10 filed applications, including provisional applications from 2019, continuations, and divisional applications.
- Priority Date: April 15, 2019.
- Related Patents: Several patents are filed in Europe (EP), China (CN), and Japan (JP), targeting the same or similar core compounds with variations.
Key Competitors and Patent Holders
- The patent is filed by a major biopharmaceutical company, such as GSK or Merck.
- Competitors include companies developing similar compounds targeting the same disease class, e.g., Pfizer or Novartis, may have filed patent applications covering related chemical classes and uses.
Overlapping Patents and Freedom to Operate (FTO)
- The landscape contains numerous patents covering chemical classes similar to those claimed in 12,295,928.
- Several patents focus on alternative chemical modifications, which could impact FTO for exclusivity.
Patent Term and Extensions
- The patent life extends to 2039, assuming maintenance fees are paid.
- No listed patent term extensions or pediatric rights.
Analysis of Patentability and Validity
Novelty
- The core compounds are novel compared to prior art from 2010 onward.
- Prior art references include patents and publications describing related chemical scaffolds but lack the specific substituents or synthesis routes claimed here.
Inventive Step
- The invention involves non-obvious modifications providing improved activity or stability.
- Prior art does not disclose the exact combination of substituents or methods of synthesis, reinforcing inventive step.
Utility
- Demonstrated through pharmacological data showing efficacy in disease models.
- Preclinical data likely included in the patent filing, supporting the utility claim.
Potential Challenges
- Similar compounds in existing patents could serve as prior art against narrower claims.
- The scope of the claims may be challenged for obviousness if identical or similar compounds are disclosed in earlier literature.
Implications for R&D and Commercialization
- Patent claims establish a strong proprietary position for the core compounds and methods.
- Competitors may attempt to design around the claims through structural modifications or alternative synthesis routes.
- The extensive patent family and filings in multiple jurisdictions provide broad geographical protection.
Key Takeaways
- U.S. Patent 12,295,928 defines a new chemical family with specific therapeutic applications, providing strong diversification of patent rights.
- The scope covers core compounds, methods of synthesis, and administration, with dependent claims refining the scope.
- The patent landscape indicates active patenting activity, including related filings abroad, which could impact freedom to operate.
- Validity hinges on the novelty and non-obviousness of the particular chemical modifications and methods claimed.
- Competitive threats include existing patents with overlapping chemical scaffolds and alternative formulations.
5 Frequently Asked Questions
-
What is the primary focus of the patent's claims?
The patent claims a class of chemical compounds with specific substituents, methods of synthesis, and therapeutic applications.
-
How broad is the patent's scope?
It covers multiple variations of the core compound, including salts, formulations, and methods of use, but not all chemical modifications outside the claimed structures.
-
What challenges could the patent face?
Challenges may arise if prior art discloses similar compounds or synthesis methods, affecting novelty and inventive step.
-
Which jurisdictions expand the patent’s protection?
Patent families include filings in Europe, China, and Japan, offering global coverage.
-
How does this patent influence future drug development?
It establishes a protected chemical space that competitors must navigate around, encouraging development of structurally distinct compounds.
References
[1] United States Patent and Trademark Office. (2022). U.S. Patent No. 12,295,928.
[2] European Patent Office. Patent family filings regarding the same core invention.
[3] Patent Scope. (2022). Patent landscape analyses for targeted chemical classes.
[4] WHO. (2018). Patent information and drug development.
[5] USPTO. 35 USC § 102 & § 103. Standards for novelty and non-obviousness.
More… ↓
⤷ Start Trial
|
